Can a blood test replace bone marrow biopsy for low blood counts?
Part of Blood & lymphatic clinical trials.
This study tries to see if blood tests can replace a bone marrow biopsy for people with low blood counts (cytopenia) and suspected MDS (myelodysplastic syndrome). It aims to make diagnosis less invasive by using a simple blood draw instead of a bone marrow sample.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have low blood counts (low platelets, low white blood cells, or low hemoglobin).
- Your low counts are NOT caused by low iron, folate, or vitamin B12.
- You do NOT have a past diagnosis of leukemia, lymphoma, or similar blood cancers.
- You have not had a bone marrow transplant.
- You are not currently receiving specific treatments for your blood condition (except some like erythropoietin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who may have early, unclear blood count problems or certain genetic/immune patterns that can later lead to bone marrow failure or blood cancers. It may help doctors better understand risks over time and guide earlier care.
This study tests whether doctors can diagnose myeloproliferative neoplasms (slow-growing blood cancers like polycythemia vera, essential thrombocythemia, or myelofibrosis) using a simple blood test instead of a painful bone marrow biopsy. If successful, patients could get diagnosed faster and more comfortably.
This study checks whether a detailed blood-cell test can help diagnose myelodysplastic syndrome (MDS), a bone marrow condition that can cause low blood counts. Your results are compared with standard bone marrow testing to see how well the blood test performs.
This study follows people with ongoing low blood counts (red cells, white cells, and/or platelets) to better understand their condition when it does not meet criteria for MDS. It may help improve how persistent blood count problems are evaluated over time.
This study uses repeated blood samples to watch how genetic changes in your blood evolve in lower-risk myelodysplastic syndrome (MDS). It may help doctors understand what mutation changes mean over time for people not on strong cancer-fighting treatments.
This study looks at the blood and bone marrow of people with pancytopenia (low levels of red blood cells, white blood cells, and platelets) to understand its causes and features. It may help doctors learn more about this condition and improve future diagnosis and care.
Hear when a new Cytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.